6505--Zolmitriptan Tablets (VA-25-00006129)
ID: 36E79724R0028Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0ff1e6d7094a4233a103f7e8ce795e7e/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.

    Point(s) of Contact
    Kenneth LayContract Specialist
    (708) 786-4879
    Kenneth.Lay@va.gov
    Files
    Title
    Posted
    36E79724R0028_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is initiating a Request for Proposal (RFP 36E79724R0028) for Zolmitriptan Tablets. This procurement targets an unrestricted supply of the medication for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. One contract will be awarded to ensure continuous availability of the specified product, with a contract term of one year plus four optional one-year extensions. The estimated annual requirements include 28,339 blister packs of Zolmitriptan 2.5mg (6 tablets per pack) and 147,600 blister packs of Zolmitriptan 5mg (3 tablets per pack). The solicitation will be issued electronically on or around September 5, 2024, with a submission deadline of September 19, 2024. Interested vendors must have an FDA-assigned NDC number and can check for updates or amendments on sam.gov. The primary point of contact for inquiries regarding this procurement is Contract Specialist Kenneth Lay, reachable via email at Kenneth.Lay@va.gov. The VA emphasizes the importance of reliable supply and compliance with federal procurement regulations for this pharmaceutical contract.
    36E79724R0028.docx
    The document outlines a government solicitation for pharmaceutical supplies specifically focused on Zolmitriptan tablets for the Department of Veterans Affairs and the Department of Defense. Key elements include contract details such as solicitation number, award date, delivery terms, and qualifications for bidders, emphasizing the requirement for prices for both the base year and four option years while ensuring compliance with the Drug Supply Chain Security Act (DSCSA). Offerors must submit unique National Drug Codes (NDC) for their products and demonstrate adherence to good manufacturing practices as mandated by the FDA. The solicitation also incorporates clauses related to contract terms and conditions, performance evaluations, subcontracting plans, and reporting obligations, focusing on maintaining a reliable supply chain and ensuring that products meet safety and regulatory standards. The overarching goal is to establish a consistent source for pharmaceutical needs within federal healthcare programs, seeking competitive pricing and compliance with established legal frameworks. The structure includes multiple sections detailing requirements, evaluations, and necessary documentation for potential contractors.
    Lifecycle
    Title
    Type
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Solicitation
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized as drugs and biologicals, indicating the importance of these tablets in the healthcare services provided to veterans. Interested vendors should reach out to the primary contact, Contracting Officer Adrienne A Albachiara, via email at Adrienne.Albachiara@va.gov for further details regarding the submission process and any deadlines associated with this opportunity.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Levothyroxine Tablets under the solicitation titled '6505--Levothyroxine Tablets (VA-24-00084562)'. This procurement aims to acquire pharmaceutical preparations, specifically Levothyroxine, which is critical for treating thyroid hormone deficiencies in veterans. The contract will fall under the NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and the PSC code 6505, indicating Drugs and Biologicals. Interested vendors can reach out to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details regarding the submission process and deadlines.
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77024Q0344
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is announcing a special notice regarding the awarding of contracts under Solicitation Number 36C77024Q0344, specifically for pharmaceutical services through the National CMOP Contracting Office. This procurement has resulted in two awards totaling $157,961.04, granted to Core Trading Company and Pharmacy Buying Association, Inc., for various line items related to pharmaceutical preparation. The awarded contracts are part of the government's ongoing efforts to efficiently procure necessary pharmaceutical services for veterans. Interested parties should contact Contracting Specialist Jeffrey Blackard at jeffrey.blackard@va.gov or call 913-684-1042, with submissions due by September 18, 2024, at 10 PM Central Time.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.